Measured PD-L1 tumor expression, categorized as <1%, 1–49%, and ≥50%, varied significantly across the four assay types (χ2 p < 0.001) and across three assay types excluding the SP142 assay (χ2 p < 0.001). Here, CD274 is linked to neoplasm.